The Right Price: A Value-Based Prescription for Drug Costs Paperback, 272 pages, ISBN: 9780197512876, published 12 October 2021 You can support the blog by buying books through one of our affiliate links. If you’re in the UK, visit our shop on… Read More »Review: The Right Price (Peter Neumann et al)
Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit… Read More »Chris Sampson’s journal round-up for 13th April 2020
Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit… Read More »Chris Sampson’s journal round-up for 13th January 2020
As many of us who have had to review submitted journal articles, thesis defenses, grant applications, white papers, and even published literature know, providing feedback on something that is poorly conceived is much harder than providing feedback on something well… Read More »Are QALYs #ableist?
Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit… Read More »Chris Sampson’s journal round-up for 11th September 2017
The cost-effectiveness threshold utilised by health technology assessment agencies, such as NICE in the United Kingdom, below which new medical technologies and interventions are considered cost-effective, is frequently discussed. NICE currently use a threshold of £20,000 to £30,000 per quality… Read More »Do we really need to change the cost-effectiveness threshold?